Last February, the Catalan Institute of Oncology held the second MTB Conference at the Bellvitge Campus, a multidisciplinary event dedicated to analysing the development of Molecular Tumour Boards (MTBs) and their impact on precision medicine. The session brought together healthcare and research professionals from the campus to share experiences and knowledge, focusing on the transfer from the laboratory to the patient and the analysis of real clinical cases. Among the attendees and organisers of the conference were David Cordero, coordinator and member of the UBOP.
Throughout the conference, key issues were addressed, such as the actionable nature of variants, secondary findings of germline origin and the value of collaborative work in research projects, as well as emphasising the need to optimise diagnostic pathways.
